콘텐츠로 건너뛰기
주식/증권 📈 긍정적

ImmuCell Q1 Earnings Rise Y/Y as Sales Climb on Strong Demand

요약

ICCC posts record Q1 sales and 34% earnings growth as demand for its First Defense calf-health products boosts margins and market share.